How PBMs limit access to MS therapies
Pharmacy benefit managers inflate specialty generic prices, restrict pharmacy choice and increase patient costs, leaving many life-saving multiple sclerosis therapies inaccessible.
Pharmacy benefit managers inflate specialty generic prices, restrict pharmacy choice and increase patient costs, leaving many life-saving multiple sclerosis therapies inaccessible.